Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-09-18
2007-09-18
Coleman, Brenda (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S555000
Reexamination Certificate
active
10966227
ABSTRACT:
This invention provides compounds of the formula:wherein R1and R2are each, independently, H, alkyl, cycloalkyl, —CH2-cycloalkyl, alkoxy, halogen, fluorinated alkyl, —CN, —NH—SO2-alkyl, —SO2—NH-alkyl, alkyl amide, amino, alkylamino, dialkylamino, fluorinated alkoxy, acyl, or phenoyl or thiophenoyl; R3and R4are each, independently, H, alkyl or cycloalkyl; R5is H or alkyl; R6is H or; and the dashed line indicates an optional double bond; or a pharmaceutically acceptable salt thereof, and pharmaceutical compositions and methods utilizing these compounds for the treatment or prevention of disorders including obsessive-compulsive disorder, depression, anxiety, generalized anxiety disorder, schizophrenia, migraine, sleep disorders, eating disorders, obesity, epilepsy, and spinal cord injury.
REFERENCES:
patent: 3235564 (1966-02-01), Wagner
patent: 3296252 (1967-01-01), Frey et al.
patent: 3329676 (1967-07-01), Bell et al.
patent: 3335134 (1967-08-01), Frey et al.
patent: 3417101 (1968-12-01), Bell et al.
patent: 3466274 (1969-09-01), DeRidder
patent: 3714149 (1973-01-01), Hepter
patent: 3914250 (1975-10-01), Kim
patent: 4997831 (1991-03-01), Bays et al.
patent: 5045545 (1991-09-01), Bays et al.
patent: 5834454 (1998-11-01), Kitano et al.
patent: 6503900 (2003-01-01), Sabb et al.
patent: 6699852 (2004-03-01), Robichaud et al.
patent: 6720316 (2004-04-01), McWhorter, Jr.
patent: 6759405 (2004-07-01), Sabb et al.
patent: 6777402 (2004-08-01), Nifantiev et al.
patent: 6777407 (2004-08-01), Sabb et al.
patent: 6858604 (2005-02-01), Sabb et al.
patent: 2002/0086860 (2002-07-01), Sabb et al.
patent: 2002/0107242 (2002-08-01), Sabb et al.
patent: 2002/0119966 (2002-08-01), Sabb et al.
patent: 2002/0173503 (2002-11-01), Robichaud et al.
patent: 2003/0050300 (2003-03-01), McWhorter Jr.
patent: 0344015 (1989-11-01), None
patent: 0357417 (1990-03-01), None
patent: 10-237073 (1998-09-01), None
patent: 930902 (1982-11-01), None
patent: WO90/15058 (1990-12-01), None
patent: WO96/29316 (1996-09-01), None
patent: WO97/30999 (1997-08-01), None
patent: WO97/31000 (1997-08-01), None
patent: WO99/66934 (1999-12-01), None
patent: WO99/67219 (1999-12-01), None
patent: WO 00/35922 (2000-06-01), None
patent: WO 00/64899 (2000-11-01), None
patent: WO 00/77002 (2000-12-01), None
patent: WO 01/12603 (2001-02-01), None
patent: WO 02/08186 (2002-01-01), None
patent: WO 02/36596 (2002-05-01), None
patent: WO 02/42304 (2002-05-01), None
patent: WO 02/059124 (2002-08-01), None
patent: WO 02/059129 (2002-08-01), None
S. Archer et al., J. Am. Chem. Soc., 79, 5783-5785 (1957).
L. Zhang et al., Tetrahedron Letters, 36(46), 8387-8390 (1995).
G.E. Stokker, Tetrahedron Letters, 37(31), 5453-5456 (1996).
Cuadro et al., Synthetic Communications, 21(4), 535-544 (1991).
W. Perkin et al., J. Chem. Soc., 123, 3242-3247 (1923).
H. Booth et al., J. Chem. Soc., 158, 2302-2311 (1958)
Gregory R. Martin et al., J. Med. Chem., 32, 1052-1056 (1989).
J.L. Browning et al., Society for Neuroscience Abstracts, Oct. 1999, 2075, 25(2), Abstract 830.12.
Jackson B. Hester et al., J. Med. Chem., 13, 827-835 (1970).
Dong H. Kim, J. Heterocycl. Chem., 13(6), 1187-92 (1976).
H.P. Harter et al., Chimia, 30, 50-52 (1976).
P.J. Cowen et al., Nature 376, 557 (Aug. 1995).
A.J. Robichaud et al., Annual Reports in Medicinal Chemistry, 35, 11-20 (2000).
D. Hoyer et al., Pharmacology & Experimental Therapeutics 46(2), 157-203 (1994).
L. Tecott et al., Nature, 374, 542-546 (Apr. 1995).
D.H. Kim, J. Heterocycl. Chem., 12, 1323-1324 (Dec. 1975).
M.J. Bishop et al., Expert Opin. Ther. Patents, 13(11), 1691-1705 (2003).
Shunji Naruto et al., Tetrahedron Letters, 39, 3399-3402 (1975).
A.N. Grinev et al., Chem. Heterocycl. Compd., 19(9), 959-961 (1983).
A.N. Grinev et al., Chem. Heterocycl. Compd., 19(12), 1312-1315 (1983).
E.V. Lamanova et al., Pharm. Chem., J., 23(2), 113-115 (1989).
D.H. Kim et al., Journal of Medicinal Chemistry, 20(2), 209-212 (1977).
L. Toscano et al., J. Heterocyclic Chem., 13, 475-480 (1976).
A. Katritzky et al., Synthesis, 10, 1487-1490 (1998).
F. Gatta et al., Edizione Scientifica, 30(8), 631-641 (1975).
W. Lopes et al., Journal of Brazilian Chemical Society, 4(1), 34-39 (1993).
Sabb Annmarie L.
Vogel Robert L.
Coleman Brenda
Fitzpatrick ,Cella, Harper & Scinto
Wyeth
LandOfFree
Cyclohepta[b][1,4]diazepino[6,7,1,-hi]indoles and derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclohepta[b][1,4]diazepino[6,7,1,-hi]indoles and derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclohepta[b][1,4]diazepino[6,7,1,-hi]indoles and derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3780489